Gene · 5587
Papers3,376
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,376
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small Molecule Inhibitors of Protein Kinase D: Early Development, Current Approaches, and Future Directions. | J Med Chem | 2023 | 36538005 | PubTator, text mining | PubMed |
| PIP kinases: A versatile family that demands further therapeutic attention. | Adv Biol Regul | 2023 | 36517396 | PubTator, text mining | PubMed |
| Non-canonical Golgi-compartmentalized Gβγ signaling: mechanisms, functions, and therapeutic targets. | Trends Pharmacol Sci | 2023 | 36494204 | PubTator, text mining | PubMed |
| Analysis of primary synchronous breast invasive ductal carcinoma and lung adenocarcinoma with next-generation sequencing: A case report. | Oncol Lett | 2023 | 36478904 | PubTator, text mining | PubMed |
| The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic. | Mol Biol Rep | 2023 | 36478297 | PubTator, text mining | PubMed |
| Phosphorylation-dependent interactions of myosin-binding protein C and troponin coordinate the myofilament response to protein kinase A. | J Biol Chem | 2023 | 36470422 | PubTator, text mining | PubMed |
| Endothelial progenitor cells in the host defense response. | Pharmacol Ther | 2023 | 36436689 | PubTator, text mining | PubMed |
| Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier. | Antiviral Res | 2023 | 36423831 | PubTator, text mining | PubMed |
| Beyond PI3Ks: targeting phosphoinositide kinases in disease. | Nat Rev Drug Discov | 2023 | 36376561 | PubTator, text mining | PubMed |
| Signaling network model of cardiomyocyte morphological changes in familial cardiomyopathy. | J Mol Cell Cardiol | 2023 | 36370475 | PubTator, text mining | PubMed |
| Expression pattern of secretory-cell-related transcriptional signatures in colon adenocarcinomas defines tumor microenvironment characteristics and correlates with clinical outcomes. | Mol Oncol | 2023 | 36349418 | PubTator, text mining | PubMed |
| The NLRP3 inflammasome: activation and regulation. | Trends Biochem Sci | 2023 | 36336552 | PubTator, text mining | PubMed |
| Comprehensive landscape and future perspectives of long noncoding RNAs (lncRNAs) in colorectal cancer (CRC): Based on a bibliometric analysis. | Noncoding RNA Res | 2023 | 36311994 | PubTator, text mining | PubMed |
| Increased intracranial pressure in a patient with Congenital Heart Defect and Ectodermal Dysplasia (CHDED): Extension of phenotype and review of literature. | Am J Med Genet A | 2023 | 36308391 | PubTator, text mining | PubMed |
| Role of Long Intergenic Noncoding RNAs in Cancers with an Overview of MicroRNA Binding. | Mol Diagn Ther | 2023 | 36287372 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| MicroRNAs: protective regulators for neuron growth and development. | Neural Regen Res | 2023 | 36204829 | PubTator, text mining | PubMed |
| Phosphorylation, compartmentalization, and cardiac function. | IUBMB Life | 2023 | 36177749 | PubTator, text mining | PubMed |
| Vitamin K Intake and Risk of Lung Cancer: The Japan Collaborative Cohort Study. | J Epidemiol | 2023 | 35871570 | PubTator, text mining | PubMed |
| Multiparameter phenotypic screening for endogenous TFEB and TFE3 translocation identifies novel chemical series modulating lysosome function. | Autophagy | 2023 | 35786165 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5587/papers?page=18